FDA recall, , Low risk
American Health Packaging Buprenorphine Sublingual Tablets
Buprenorphine Sublingual Tablets have a labeling mix-up.
Summary by Recall Canary from the FDA notice
What happened
American Health Packaging of Columbus, Ohio is recalling Buprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, due to a labeling mix-up. The recall involves 10,953 cartons distributed nationwide. The company began the recall on August 19, 2026, and the FDA added it to the Enforcement Report on August 31, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Match the NDC and lot code listed under your product.
An NDC (National Drug Code) is usually printed on the drug's label.
Buprenorphine Sublingual Tablets
- NDC
- 60687-481-21
- 60687-481-11
- Lot code
- 1030023
Recall details
- Company began the recall
- Sold in
US Nationwide.
- Company
- American Health PackagingColumbus, Ohio
- Hazard
- Labeling error
- Risk
Low risk
Taking it is unlikely to cause health problems.
FDA Class III recall · How risk is rated
- Event ID
- 99674
- Recall number
- D-0840-2026
- Quantity recalled
- 10,953 cartons.
All recalls from American Health Packaging
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report
Listed on Recall Canary
In FDA's weekly enforcement report
Classified by FDA
Summary updated
